Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Journal of Chinese Materia Medica ; (24): 1737-1748, 2018.
Article in Chinese | WPRIM | ID: wpr-690720

ABSTRACT

With the development and change of Uygur medicine, The sources,medicinal parts and producing area of some Uygur Medicine have changed. It is more important to master the classification, distribution and change of Uygur medicinal materials. These were more than 1 200 kinds Uygur medicine in history were resaerched by field investigation, philological research, and textual research, which main source of original plant were 140 families, 510 genera, 840 species; and source of original animal were 76 families, 107 genera, the original animal 141 species; 55 kinds of original mineral, which main producer were Xinjiang and Central Asia, West Asia, the Mediterranean, and North Africa, Southeast Asia and other provinces in China, there are individual medicinal materials from the Americas, Europe and other places. Through this study the classification, distribution, source and evolution of specific families and genera of Uygur medicine resources have mastered.It is hoped to provide theoretical basis for further research and development of Uygur medicinal materials.

2.
Recent Advances in Ophthalmology ; (6): 988-992, 2017.
Article in Chinese | WPRIM | ID: wpr-657796

ABSTRACT

Early treatment including cryotherapy,laser therapy and intravitreal anti-VEGF agent injection for retinopathy of prematurity with threshold retinopathy of prematurity (ROP),prethreshold ROP (type I) or aggressive posterior ROP (AP-ROP) have certain effect on ocular structure,development and refractive status.And this paper will give a review on the latest advance in refractive status after the early treatment for severe ROP.

3.
Recent Advances in Ophthalmology ; (6): 988-992, 2017.
Article in Chinese | WPRIM | ID: wpr-660235

ABSTRACT

Early treatment including cryotherapy,laser therapy and intravitreal anti-VEGF agent injection for retinopathy of prematurity with threshold retinopathy of prematurity (ROP),prethreshold ROP (type I) or aggressive posterior ROP (AP-ROP) have certain effect on ocular structure,development and refractive status.And this paper will give a review on the latest advance in refractive status after the early treatment for severe ROP.

SELECTION OF CITATIONS
SEARCH DETAIL